Skip to main content
. Author manuscript; available in PMC: 2014 May 23.
Published in final edited form as: Biochem Biophys Res Commun. 2013 Mar 21;434(4):705–709. doi: 10.1016/j.bbrc.2013.03.032

Fig. 2.

Fig. 2

Genetic heterozygosity or functional inhibition of acid sphingomyelinase normalizes ceramide in lungs of cystic fibrosis mice. Ceramide was measured in lung extracts of wildtype, Cftr-deficient mice, Cftr-deficient mice heterozygous for acid sphingomyelinase or Cftr-deficient mice treated for 6.5 months with amitriptyline or fluoxetine. Ceramide was analyzed by a ceramide kinase assay. Data are the mean ± SD with n = 5 per group, ***p < 0.001 as indicated.